We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Personal PCR Analyzer Aims to Enable At-Home Infectious Disease Testing

By LabMedica International staff writers
Posted on 02 Nov 2026

PCR amplifies DNA to enable highly accurate testing, but its reliance on complex, expensive laboratory analyzers has traditionally kept many workflows in centralized settings. More...

A new personal DNA analyzer aims to extend PCR testing to the home through a compact platform that combines disposable cartridges with automated analysis.

Sparrow Bio’s first USD 100 personal DNA analyzer is a four-inch-tall device roughly the size of a coffee cup. Within this compact format, it integrates DNA collection, extraction, thermal cycling, real-time optical detection, and automated analysis into a single system. Testing uses disposable cartridges, with results displayed on a built-in screen. Depending on the test performed, the complete workflow from sample collection to result takes 30–60 minutes.

The platform relies on PCR, a DNA amplification chemistry that enables highly accurate testing. To make this technology more affordable, Sparrow Bio reported using new technologies that reduce manufacturing costs by up to 50 times compared with existing laboratory-based PCR instruments. The company estimates analyzer manufacturing costs at USD 135 for production volumes of 1,000 units, falling below USD 100 at higher volumes. Similarly, estimated cartridge costs are USD 7 at volumes of 10,000 units and less than USD 2 at higher volumes.

Sparrow Bio is seeking strategic partners to fund the development and regulatory clearance of testing products for its platform. Potential applications include infectious disease testing for chlamydia, gonorrhea, influenza, strep throat, and tuberculosis, alongside testing for genetic risks, cancer, and pathogens in food and water.

The team’s previous products include the Spartan RX CYP2C19 System, which received two U.S. Food and Drug Administration (FDA) 510(k) clearances, and the Kenota 1 point-of-care allergy testing platform, which received FDA 510(k) clearance and a Clinical Laboratory Improvement Amendments (CLIA) Waiver. The Sparrow analyzer is currently for research use only and is not for use in diagnostic procedures.

“Just like mainframe computers gave way to smartphones, DNA testing will move out of the lab and into the home,” said Paul Lem, M.D., CEO of Sparrow Bio. “Our vision is you will be able to test yourself for infectious diseases. If you test positive, you will have a video call with your doctor, receive an electronic prescription, and get medication delivered to your door.”

Related Links
Sparrow Bio


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Immunofluorescence Analyzer
IFA System
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The MIRAM GAGome Kit quantifies urine CS disaccharides by UHPLC-MS/MS, supporting exploratory and translational research across disease areas. (Photo courtesy of Elypta)

Study Finds Urine Biomarker Score Improves Five-Year Cancer Risk Prediction

Cancer risk stratification in healthy adults often relies on established factors such as age and smoking history. However, several cancers highlighted in the study, including pancreatic, kidney, and brain... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.